News & Press Releases

Integrity Applications Announces Close of $12 Million Private Placement

August 2nd, 2017

Integrity Applications Announces Close of $12 Million Private Placement Wilmington, Delaware, and Ashdod, Israel, August 2nd, 2017 — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced today that it has successfully closed a private placement offering, raising approximately $12 […]

Read More Download

Archive

Sign up to our newsletter
To receive occasional news updates

LinkedIn Facebook Twitter

GlucoTrack® intended use: GlucoTrack® Model DF-F is a non-invasive intermittent glucose monitoring device for home-use. GlucoTrack® model DF-F is intended for adults 18 years and older with type 2 diabetes or pre-diabetes.

Medications intake and/or treatment decisions should not be based solely on GlucoTrack® model DF-F measurements. GlucoTrack® Model DF-F is a glucose monitoring device and should not be used for diagnosis purposes.

© 2022 Integrity Applications. All Rights Reserved.